Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;20(7):1170-5.
doi: 10.3201/eid2007.121004.

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections

Matthew E Falagas et al. Emerg Infect Dis. 2014 Jul.

Abstract

We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012. Attributable death was defined as the difference in all-cause deaths between patients with carbapenem-resistant infections and those with carbapenem-susceptible infections. Online databases were searched, and data were qualitatively synthesized and pooled in a metaanalysis. Nine studies met inclusion criteria: 6 retrospective case-control studies, 2 retrospective cohort studies, and 1 prospective cohort study. Klebsiella pneumoniae was the causative pathogen in 8 studies; bacteremia was the only infection in 5 studies. We calculated that 26%-44% of deaths in 7 studies were attributable to carbapenem resistance, and in 2 studies, which included bacteremia and other infections, -3% and -4% of deaths were attributable to carbapenem resistance. Pooled outcomes showed that the number of deaths was significantly higher in patients with carbapenem-resistant infections and that the number of deaths attributable to carbapenem resistance is considerable.

Keywords: Enterobacteriaceae; KPC; Klebsiella pneumoniae; Klebsiella pneumoniae carbapenemase; attributable deaths; attributable mortality; bacteremia; bacteria; bloodstream infection; carbapenem resistance; carbapenem-resistant Enterobacteriaceae; carbapenemase-producing; carbapenemases; deaths; infections; meta-analysis; metaanalysis; mortality; outcome; systematic review.

PubMed Disclaimer

Figures

Figure
Figure
Selection process for studies included in a systematic review and metaanalysis of deaths attributable to carbapenem-resistant Enterobacteriaceae infections. CRE, carbapenem-resistant Enterobacteriaceae; CSE, carbapenem-susceptible Enterobacteriaceae; KPC, Klebsiella pneumoniae carbapenemase; ESBL, extended-spectrum β-lactamase.

References

    1. Hu F, Chen S, Xu X, Guo Y, Liu Y, Zhu D, et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J Med Microbiol. 2012;61:132–6 .10.1099/jmm.0.036483-0 - DOI - PubMed
    1. Zarfel G, Hoenigl M, Wurstl B, Leitner E, Salzer HJ, Valentin T, et al. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001–2010. Clin Microbiol Infect. 2011;17:E5–8 .10.1111/j.1469-0691.2011.03659.x - DOI - PubMed
    1. Daikos GL, Karabinis A, Paramythiotou E, Syriopoulou VP, Kosmidis C, Avlami A, et al. VIM-1–producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases. Int J Antimicrob Agents. 2007;29:471–3 .10.1016/j.ijantimicag.2006.11.006 - DOI - PubMed
    1. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53:1868–73 .10.1128/AAC.00782-08 - DOI - PMC - PubMed
    1. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20:440–58 .10.1128/CMR.00001-07 - DOI - PMC - PubMed

MeSH terms